Recent and upcoming legalization of cannabis for medical purposes, due to its anti-spasmodic and anti-proliferative properties, has led to the growth of the industry globally. Increasing investment in R&D and clinical trials in the coming years will further lead to robust growth in the global medical cannabis market.

As per the latest research report by IMARC Group, the global medical cannabis market reached a value of US$ 13.4 Billion in 2018. Medical cannabis is obtained from the Cannabis Sativa and Cannabis Indica plants.